June 3, 2021 by Chain Drug Review
National Community Pharmacists Association, NCPA chief executive officer B. Douglas Hoey
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The CEO of the country’s largest organization of community pharmacies today called for immediate action after the Centers for Medicare & Medicaid Services disclosed in a budget document that pharmacy benefit managers increased retroactive fees on pharmacies by an astonishing 91,500 percent in recent years. “This is absolutely unsustainable,” said B. Douglas Hoey,
June 2, 2021 by Chain Drug Review
National Community Pharmacists Association, NCPA chief executive officer B. Douglas Hoey
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The national labor shortage that has small employers scrambling for workers is also affecting front-line health care providers, according to a new survey released today by the National Community Pharmacists Association. “This is a major challenge for community pharmacies that are seeing many more patients because of the pandemic,” said NCPA CEO B.
December 9, 2020 by Chain Drug Review
mail order drugs, NCPA chief executive officer B. Douglas Hoey
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — A nationwide survey of independent pharmacists, released Wednesday by the National Community Pharmacists Association, finds a host of alarming problems with mail order prescriptions, including late deliveries, errant deliveries, and sensitive drugs left out in the elements. “Do-it-yourself health care is dangerous, and we’re seeing some of the risks in this data,”said NCPA CEO B.
September 2, 2020 by Chain Drug Review
National Community Pharmacists Association, NCPA chief executive officer B. Douglas Hoey
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — With most rural and medically underserved communities relying on the services of independent community pharmacies, integrating these neighborhood pharmacies in coronavirus immunization plans is key in achieving widespread vaccine administration. National Community Pharmacists Association CEO B. Douglas Hoey emphasized independent pharmacists’ accessibility and value to patients to the Trump administration today on
September 2, 2020 by Chain Drug Review
Debra Billingsley, NCPA, NCPA chief executive officer B. Douglas Hoey, Oklahoma Pharmacists Association
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The National Community Pharmacists Association welcomed a development in a federal court case in which the powerful pharmacy benefit manager lobby is challenging an Oklahoma law that would regulate PBMs, protect patient access, and ensure fairer business practices. “This is a very positive development in a very important case,” said NCPA CEO B.
August 31, 2020 by Chain Drug Review
National Community Pharmacists Association, NCPA chief executive officer B. Douglas Hoey
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — A new survey by the National Community Pharmacists Association shows sky-high interest in delivering coronavirus vaccines when they are approved. “Community pharmacists are already doing immunizations, so this is a natural expansion of the health care services they’re already providing,” said NCPA CEO B. Douglas Hoey. The survey finds that 86% of community pharmacists say
April 28, 2020 by Chain Drug Review
Fight4Rx, NCPA, NCPA chief executive officer B. Douglas Hoey, pharmacy benefit managers (PBMs)
Issues, Leading Headlines, Pharmacy

ALEXANDRIA, Va. — As pharmacy benefit managers continue to prioritize profits ahead of patients, the National Community Pharmacists Association has launched Fight4Rx to alert patients to the growing risk that their neighborhood pharmacy may close, not because of COVID-19 but because of excessive profiteering. “PBMs are the middlemen responsible for managing prescription drug benefits for the majority
June 26, 2019 by Chain Drug Review
Fix DIR Day, National Community Pharmacists Association, NCPA chief executive officer B. Douglas Hoey
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The National Community Pharmacists Association and its 22,000 member pharmacies are launching Fix DIR Day on Thursday, June 27. Pharmacy stakeholders will be mobilizing their legislators in Congress to contact members of the Senate Finance Committee and urge them to address pharmacy direct and indirect remuneration fees, or pharmacy DIR, in their
May 22, 2019 by Chain Drug Review
NCPA chief executive officer B. Douglas Hoey, Oklahoma Gov. Kevin Stitt, Oklahoma PBM regulation law, Oklahoma Pharmacists Association
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — Oklahoma Gov. Kevin Stitt Tuesday signed into law HB 2632, which protects patient access to pharmacy services by establishing network adequacy and “any willing pharmacy” requirements, minimizes pharmacy benefit manager conflicts of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies, and limits PBM abuses by prohibiting retroactive claim adjustments and denials.